RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China Shineway Pharmaceutical Group Stock

China Shineway Pharmaceutical Group ROE 2024

China Shineway Pharmaceutical Group ROE

0.14

Ticker

2877.HK

ISIN

KYG2110P1000

WKN

A0DNLW

In 2024, China Shineway Pharmaceutical Group's return on equity (ROE) was 0.14, a 21.7% increase from the 0.11 ROE in the previous year.

China Shineway Pharmaceutical Group Aktienanalyse

What does China Shineway Pharmaceutical Group do?

China Shineway Pharmaceutical Group Ltd was founded in 1996 and has since become one of the leading Chinese pharmaceutical companies. Based in Beijing, the company offers a wide range of products in various segments, including traditional Chinese medicine, Western medicine, and health products. China Shineway's business model is based on research and development, production, distribution, and marketing of pharmaceutical products. The company strives to advance the development of new drugs and treatment methods by continuously improving its research and development department. The company covers various areas of healthcare, including the manufacturing of remedies for cancer, cardiovascular diseases, orthopedic surgery, and neurology. China Shineway also specializes in the development of herbal medicines for use in traditional Chinese medicine. The company has thus occupied a niche market and is an important provider of natural remedies for various health needs in this niche. Another important aspect of Shineway's business is the production of raw materials for use in other pharmaceutical products. The company has a strong presence in the Chinese market and supplies other companies with pharmaceutical raw materials for drug manufacturing. The company continuously improves its production capacity and implements new technologies for the production of high-quality goods. One of the most well-known products in traditional Chinese medicine at Shineway is Naoxintong. Naoxintong is an herbal medicine used for the treatment of cardiovascular diseases and helps to lower cholesterol levels and blood pressure. The combination of natural plant extracts is unique and has found great demand in China. Another product segment of China Shineway is the business of health products. The company offers high-quality dietary supplements, vitamins, and minerals to improve overall well-being and physical health. The company is committed to ensuring the highest level of quality and safety in all its products. The company also operates a strong international business by exporting its products worldwide. China Shineway has branches in several countries, including Europe, Africa, and Asia, creating access to global markets. Due to the high demand for natural remedies in traditional Chinese medicine, the company has made significant progress in international markets in recent years. China Shineway also has a strong social responsibility and supports numerous charitable and nonprofit organizations in China. The company has launched a donation initiative and distributed medicines and health products for free to those who could not afford them. It is also committed to protecting the environment and invests in environmentally friendly technologies to reduce its carbon footprint. Overall, China Shineway has established itself as an important company in the Chinese pharmaceutical industry and has managed to be successful both internationally and in the domestic market. The company is committed to continuing its commitment to research and development to provide even better drugs and treatment methods in the future. China Shineway Pharmaceutical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding China Shineway Pharmaceutical Group's Return on Equity (ROE)

China Shineway Pharmaceutical Group's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing China Shineway Pharmaceutical Group's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

China Shineway Pharmaceutical Group's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in China Shineway Pharmaceutical Group’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about China Shineway Pharmaceutical Group stock

What is the ROE (Return on Equity) of China Shineway Pharmaceutical Group this year?

The ROE of China Shineway Pharmaceutical Group this year is 0.14 undefined.

How has the Return on Equity (ROE) of China Shineway Pharmaceutical Group developed compared to the previous year?

The ROE of China Shineway Pharmaceutical Group has increased by 21.7% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of China Shineway Pharmaceutical Group?

A high ROE indicates that China Shineway Pharmaceutical Group generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of China Shineway Pharmaceutical Group?

A low ROE can indicate that China Shineway Pharmaceutical Group is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of China Shineway Pharmaceutical Group affect the company?

A change in ROE (Return on Equity) of China Shineway Pharmaceutical Group can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of China Shineway Pharmaceutical Group?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of China Shineway Pharmaceutical Group?

Some factors that can influence China Shineway Pharmaceutical Group's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does China Shineway Pharmaceutical Group pay?

Over the past 12 months, China Shineway Pharmaceutical Group paid a dividend of 0.47 CNY . This corresponds to a dividend yield of about 5.57 %. For the coming 12 months, China Shineway Pharmaceutical Group is expected to pay a dividend of 0.49 CNY.

What is the dividend yield of China Shineway Pharmaceutical Group?

The current dividend yield of China Shineway Pharmaceutical Group is 5.57 %.

When does China Shineway Pharmaceutical Group pay dividends?

China Shineway Pharmaceutical Group pays a quarterly dividend. This is distributed in the months of October, May, June, October.

How secure is the dividend of China Shineway Pharmaceutical Group?

China Shineway Pharmaceutical Group paid dividends every year for the past 22 years.

What is the dividend of China Shineway Pharmaceutical Group?

For the upcoming 12 months, dividends amounting to 0.49 CNY are expected. This corresponds to a dividend yield of 5.83 %.

In which sector is China Shineway Pharmaceutical Group located?

China Shineway Pharmaceutical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Shineway Pharmaceutical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Shineway Pharmaceutical Group from 9/27/2024 amounting to 0.12 CNY, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.

When did China Shineway Pharmaceutical Group pay the last dividend?

The last dividend was paid out on 9/27/2024.

What was the dividend of China Shineway Pharmaceutical Group in the year 2023?

In the year 2023, China Shineway Pharmaceutical Group distributed 0.383 CNY as dividends.

In which currency does China Shineway Pharmaceutical Group pay out the dividend?

The dividends of China Shineway Pharmaceutical Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Shineway Pharmaceutical Group

Our stock analysis for China Shineway Pharmaceutical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Shineway Pharmaceutical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.